- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03387735
Multiple Chronic Conditions for Older Adults
Heart-Related Multiple Chronic Conditions in Primary Care: Behavioral Technology
Multiple chronic conditions are common and expensive among patients aged ≥65 and are associated with lower quality of life, poorer response to treatment, worse medical and psychiatric outcomes, higher mortality, and higher costs of care.
The primary purpose of this study is to conduct a randomized clinical trial (RCT) to examine the effects of ElderTree --a web-based intervention--on health outcomes and healthcare use among older adults with several chronic health conditions, such as diabetes, high blood pressure, high cholesterol, COPD, BMI over 30, congestive heart failure, chronic kidney disease, arrhythmia/atrial fibrillation, chronic pain, arthritis.
The investigator's hypothesis is that patients assigned to TAU+ElderTree will have better quality of life and fewer primary care visits than those assigned to TAU+Internet.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53704
- UW Health Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- are ≥65 years old
- have been treated in the University of Wisconsin Health clinics for at least the previous 18 months with no plans to leave during the study period
- have 3 or more of the following chronic conditions: hypertension, hyperlipidemia, diabetes, arthritis, BMI over 30, chronic kidney disease, congestive heart failure, arrhythmia/atrial fibrillation, pulmonary heart disease or pulmonary vascular disease, chronic pain, COPD
- report no current psychotic disorder that would prevent participation
- have no acute medical problem requiring immediate hospitalization
- be able to read and sign the consent form in English
- have no known terminal illness
be willing to share health-related study data and
- Systolic and diastolic BP
- Weight
- BMI
- HDL/LDL
- HbA1C
- pain score
- lung function
- health care utilization: number of ER visits, urgent care visits, primary care visits and specialty care visits
- allow researchers to share information with their primary care physician
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Treatment as usual (TAU) + Internet
Patients will be given access to helpful websites such as National Institute on Aging.
|
Patients in this group will receive TAU+internet and links to helpful websites.
|
Experimental: Treatment as usual (TAU) + ElderTree
Patients will be given access to the ElderTree website for 12 months which provides tools, motivation, and social support to help them manage their specific set of chronic conditions and communicate with peers and their primary care physician.
|
For the patient, ElderTree provides tools, motivation, and social support to help them manage their specific set of chronic conditions and communicate with peers and their primary care physician. For the clinic, ElderTree has a Clinician Report (CR), a visual dashboard of health-tracking data that can be customized based on the needs of the clinic. The CR provides alerts to the clinician when a patient passes a certain threshold. The dashboard is intended to help clinicians prepare for patient office visits. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PROMIS Global Health Measure Score
Time Frame: Measured at baseline and 12 months
|
Quality of life is assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health measure.
For consistency with other measures, the time frame has been modified to refer to the past 2 weeks.
Scores are calculated using the HealthMeasures Scoring Service.
Scores are a T-score metric with a mean of 50 and a standard deviation of 10 with a range of about 20 to 80. Higher scores indicate better quality of life.
|
Measured at baseline and 12 months
|
Psychological Flourishing Scale
Time Frame: Baseline and 12-months
|
Psychological well-being is assessed using the Psychological Flourishing Scale.
The wording of items has been somewhat modified, including simplifying double-barreled items.
For example, "I lead a purposeful and meaningful life" is shortened to "I lead a meaningful life."
Scores are a sum of all items with a range from 8 to 40.
Higher scores indicate a better well-being.
|
Baseline and 12-months
|
UCLA Loneliness Scale
Time Frame: Baseline and 12-months
|
Loneliness is measured using the 8 items from the UCLA Loneliness Scale with the highest factor loadings among older adults.
Scores ranged from 8 to 40.
Higher scores indicate more loneliness.
|
Baseline and 12-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Unhealthy Laboratory Scores
Time Frame: 12-months
|
Laboratory scores are obtained from the patient's electronic health record (EHR) including blood pressure, HAC1 for diabetes, cholesterol, BMI.
Some participants did not have this data.
The final score is a fraction of the number of unhealthy labs over each persons total labs.
Scores range from 0 to 1. Higher scores indicate more unhealthy lab records.
|
12-months
|
Falls
Time Frame: Baseline and 12-months
|
Falls were assessed by asking how often the participant had fallen in the past 3 months.
A fall is defined in the survey as "the body going to the ground without being pushed."
Here we report statistics for how many times participants had fallen.
Falls ranged from 0 to 14.
|
Baseline and 12-months
|
Symptom Distress
Time Frame: Baseline and 12-months
|
Symptom distress is assessed using a combined list of 20 symptoms and chronic conditions from the General Symptom Distress Scale and Bayliss Disease Burden Scale, assessing the severity of distress for each over the past 2 weeks (0=do not have this, 1=not very distressing, and 5=extremely distressing).
Scores range from 0 to 100.
Higher scores indicate more symptom distress.
|
Baseline and 12-months
|
Medication Adherence
Time Frame: Baseline and 12-months
|
Medication adherence is assessed with 8 items, 6 based on the Brief Medication Questionnaire by Svarstad et al.
We simplified response options so that participants rate how often they had specific issues with medication (1=never and 5=always).
On the basis of patients' experiences, we added 2 original items, "Feels like I no longer need it" and "Feels like I don't need the full dose.
There were 8 items in total, summed to get a final score.
Scores ranged from 8 to 40.
Higher scores indicate less medication adherence.
|
Baseline and 12-months
|
Crisis Health Care Visits
Time Frame: Baseline and 12-months
|
Crisis health care was the total number of urgent care visits, emergency room visits, and hospitalizations combined.
Reported is the average count of visits.
Higher numbers indicate more visits.
|
Baseline and 12-months
|
Long-term Care
Time Frame: Baseline and 12-months
|
Long-term care was the number of nights spent in assisted living facilities and nursing homes over the past 3 months.
Number of nights ranged from 0 to 92.
Higher numbers indicate more nights spent.
|
Baseline and 12-months
|
Falls Requiring Medical Attention
Time Frame: Baseline and 12-months
|
Falls requiring medical attention was assessed by one item counting the number of times in the past 3 months.
A fall is defined in the survey as "the body going to the ground without being pushed."
Here we report statistics for how many times participants had fallen and required medical attention.
Falls needing medical attention ranged from 0 to 4.
|
Baseline and 12-months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: David H Gustafson, PhD, University of Wisconsin, Madison
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-0849
- A195010 (Other Identifier: UW Madison)
- ENGR\INDUSTRIAL ENGR\CHESS (Other Identifier: UW Madison)
- 1R01HL134146-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsActive, not recruitingChronic Conditions, Multiple | Chronic ConditionDenmark
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of Alabama at BirminghamRecruitingDisability Physical | Chronic Conditions, Multiple | Chronic ConditionUnited States
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Radboud University Medical CenterRecruiting
-
Virta HealthActive, not recruitingDisease Progression | Chronic Disease | Telemedicine | Multiple Chronic Conditions | Long-Term CareUnited States
Clinical Trials on Treatment as usual (TAU) + Internet
-
Karolinska InstitutetRecruiting
-
Centro Mente Aberta de MindfulnessUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...KU Leuven; ZonMw: The Netherlands Organisation for Health Research and Development and other collaboratorsRecruiting
-
Hospital Universitari Vall d'Hebron Research InstituteParc Sanitari Sant Joan de Déu; Universitat Autonoma de BarcelonaCompleted
-
Centre for Addiction and Mental HealthCompleted
-
Karolinska InstitutetRegion StockholmCompleted
-
Virginia Commonwealth UniversityCompletedSubstance Use Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Drug Dependence | Drug Use Disorders | Substance AddictionUnited States
-
Nova Scotia Health AuthorityCompletedEating DisordersCanada
-
University of OsloOslo University HospitalCompletedPain, Postoperative | Breast Cancer | FatigueNorway
-
University of BariUniversity of Dublin, Trinity CollegeCompletedRecovery | Mental Disorder | Schizophrenia and Related Disorders | Intellectual Disability, Mild to Moderate | Personality Disorders and Disturbances in Behavior | Personality Disorders, AntisocialItaly